Skip To Main Content
Vidal Albarran on Muck Rack

Vidal Albarran

As seen in: Dialnet - Universidad de La Rioja, eCancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Vidal

Contact Vidal, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone

|
By Nigel P Murray, Ricardo Villalon, Vidal Albarran
| eCancer Verified
How likely is this article to improve patient care in your region? Is reading this article likely to improve your clinical practice? How likely are you to recommend this article to a colleague?
Open in Who Shared Issue with article?

Metástasis ovárica de primario colónico

|
By Ricardo Villalón C, Vidal Albarran, Carlos Fernandez
| Dialnet - Universidad de La Rioja
Open in Who Shared Issue with article?

Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone

|
By Nigel P Murray, Sócrates Aedo, Ricardo Villalon, Vidal Albarran
| eCancer Verified
Nigel P Murray, Sócrates Aedo, Ricardo Villalon, Vidal Albarran, Shenda Orrego, Eghon Guzman Introduction: Twenty-five percent of stage II colon cancer (CC) patients relapse within 5 years due to minimal residual disease (MRD) not eliminated by surgery. We hypothesise that subtypes of MRD, defined by circulating tumour cells (CTCs) and bone marrow micrometastasis (mM), have different types and kinetics of relapse.
Open in Who Shared Issue with article?
See all 3 articles